These Results Compare Well with 65.2% Efficacy Against Delta Variant Obtained During ... - Latest Tweet by ANI
The latest Tweet by ANI states, 'These results compare well with 65.2% efficacy against Delta variant obtained during controlled phase 3 clinical trials of COVAXIN conducted among general population. Study also shows,COVAXIN meets WHO efficacy criteria for COVID19 vaccines for dreaded Delta variant:BharatBiotech ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)